Pregled bibliografske jedinice broj: 191885
A dynamical model for the separation of secondary resistance from tolerance to nitroglycerin infusion
A dynamical model for the separation of secondary resistance from tolerance to nitroglycerin infusion // International journal of clinical pharmacology, therapy and toxicology, 31 (1993), 12-17 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 191885 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
A dynamical model for the separation of secondary resistance from tolerance to nitroglycerin infusion
Autori
Miličević, Goran ; Vrhovac, Božidar ; Planinc, Danijel
Izvornik
International journal of clinical pharmacology, therapy and toxicology (0174-4879) 31
(1993);
12-17
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
nitroglycerin; drug tolerance; drug resistence; methodology
Sažetak
A dynamic model for the estimation of a residual hypotensive efficacy of nitroglycerin (NG) infusion was constructed to distinguish secondary resistance from tolerance to NG, as lost vs weakened efficiency. The model was tested by individual comparison in 82 of 92 patients with acute myocardial infarction or unstable angina. Ten patients were excluded from the study protocol due to complications that required therapy modification. NG infusion (20 micrograms/ml) efficiency was initially confirmed by a 10% decrease in the mean brachial artery (cuff) blood pressure. The infusion (63 hours mean duration) was discontinued every 12 hours for 30 minutes and pressure changes were analyzed. If NG hypotensive efficacy was maintained (as proved by at least 10% pressure increase), infusion was carried on using the initial dose. Lack of 10% pressure increase after 30-minute infusion discontinuity (tolerance) indicated the need for an increase in the NG dose until 10% pressure decrease (not below 105/60) was obtained. Lack of 10% pressure decrease, with a 5-fold increase in NG dose (up to 320 micrograms/ml), was considered to be a sign of secondary resistance. There were no proceeding complications and tolerance was found in 72 patients. Beside tolerance, secondary resistance was simultaneously present in 16 patients, while the NG efficacy was restored by dose increase in the remaining 78% of tolerant patients. "Paradoxical" pressure decrease was noted in 12 tolerant patients after the infusion interruption, while "paradoxical" pressure increase was observed in 3 resistant patients during the infusion acceleration.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Institut za antropologiju
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Scopus
- MEDLINE